Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Gemcitabine and Cisplatin in Metastatic Nasopharyngeal Carcinoma
NCT01915134Phase 3Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Aug 2013
- Primary completion
- Jan 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of endostar in nasopharyngeal carcinoma (NPC), sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
endostar
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01915134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01915134.